AtriCure Market Cap 2006-2019 | ATRC
AtriCure market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AtriCure market cap as of March 30, 2020 is $1.23B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.227B | $0.231B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $131.482B | 23.01 |
| Medtronic (MDT) | Ireland | $120.468B | 16.20 |
| Stryker (SYK) | United States | $59.680B | 19.28 |
| Boston Scientific (BSX) | United States | $42.738B | 19.25 |
| Baxter (BAX) | United States | $40.475B | 0.00 |
| Coloplast (CLPBY) | Denmark | $29.624B | 45.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $29.586B | 0.00 |
| Terumo (TRUMY) | Japan | $24.707B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $24.477B | 0.00 |
| ResMed (RMD) | United States | $20.528B | 35.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.596B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.397B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.257B | 0.00 |
| Insulet (PODD) | United States | $11.048B | 675.96 |
| Bio-Rad Laboratories (BIO) | United States | $9.648B | 45.09 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.714B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.668B | 19.18 |
| Perrigo (PRGO) | Ireland | $6.275B | 11.44 |
| GN STORE NORD (GNNDY) | Denmark | $5.486B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.097B | 0.00 |
| Haemonetics (HAE) | United States | $5.078B | 31.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Quidel (QDEL) | United States | $3.950B | 34.67 |
| ICU Medical (ICUI) | United States | $3.899B | 25.46 |
| Neogen (NEOG) | United States | $3.088B | 52.31 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.652B | 0.00 |
| NuVasive (NUVA) | United States | $2.447B | 18.92 |
| Agios Pharmaceuticals (AGIO) | United States | $2.403B | 0.00 |
| Envista Holdings (NVST) | United States | $2.359B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.316B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.599B | 26.93 |
| Aurora Cannabis (ACB) | Canada | $1.204B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.197B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.075B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.879B | 0.00 |
| Aphria (APHA) | $0.879B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $0.820B | 16.21 |
| VAREX IMAGING (VREX) | United States | $0.770B | 15.99 |
| InMode (INMD) | Israel | $0.705B | 0.00 |
| Cerus (CERS) | United States | $0.702B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.642B | 0.00 |
| PetIQ (PETQ) | United States | $0.606B | 16.50 |
| Omeros (OMER) | United States | $0.602B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.549B | 32.63 |
| OraSure Technologies (OSUR) | United States | $0.504B | 62.54 |
| Quanterix (QTRX) | United States | $0.482B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.481B | 10.82 |
| LeMaitre Vascular (LMAT) | United States | $0.458B | 25.80 |
| Surmodics (SRDX) | United States | $0.455B | 52.34 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.363B | 0.00 |
| Owens & Minor (OMI) | United States | $0.347B | 9.50 |
| Zynex (ZYXI) | United States | $0.338B | 36.79 |
| HEXO (HEXO) | $0.310B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.301B | 12.12 |
| Utah Medical Products (UTMD) | United States | $0.292B | 20.88 |
| Repro-Med Systems (KRMD) | United States | $0.291B | 183.00 |
| MacroGenics (MGNX) | United States | $0.286B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.212B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.192B | 117.38 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.162B | 18.30 |
| Rockwell Medical (RMTI) | United States | $0.151B | 0.00 |
| United Health Products (UEEC) | United States | $0.148B | 0.00 |
| Evolus (EOLS) | United States | $0.139B | 0.00 |
| Bovie Medical (APYX) | United States | $0.124B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.124B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.110B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 6.76 |
| Chimerix (CMRX) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.072B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.069B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.069B | 0.00 |
| United-Guardian (UG) | United States | $0.061B | 12.86 |
| Nephros (NEPH) | United States | $0.059B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.054B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.052B | 0.00 |
| Surface Oncology (SURF) | United States | $0.051B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.019B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.001B | 0.00 |
